Works from 2018
Identification, prioritization, and treatment of mutations identified by next-generation sequencing, Aaron S Mansfield, Ben Ho Park, and Michael P. Mullane (Book Chapter)
Implementing precision medicine programs and clinical trials in the community-based oncology practice: barriers and best practices, Jennifer L Ersek, Lora J Black, Michael A. Thompson, et al. (Book Chapter)
Multidisciplinary management of oligometastatic soft tissue sarcoma, Juneko E Grilley-Olson, Nicholas P. Webber, David S. Demos, et al. (Book Chapter)
The effects of checkpoint blockade and a CD40 agonist on T-independent and T-dependent antibody responses in mice: implications for optimization of vaccination strategies in patients receiving immunotherapies, Karen Michel, Ashley Gehrand, Michael A. Thompson, et al. (Article)
The effects of checkpoint blockade and a CD40 agonist on T-independent and T-dependent antibody responses in mice: implications for optimization of vaccination strategies in patients receiving immunotherapies, Karen Michel, Ashley Gehrand, Michael A. Thompson, et al. (Article)
Drug-specific videos for patient chemotherapy education, James Weese, Kerry A. Twite, Marija Bjegovich-Weidman, et al. (Article)
RETRACTED: Sentinel lymph node mapping in endometrioid endometrial cancer: does it work in the real world? [22A], Olga Valieva, Danielle M. Greer, Jessica J. Kram, et al. (Abstract)
The Needs of Women Treated for Ovarian Cancer: Results From a #gyncsm Twitter Chat, Teresa Hagan Thomas, Karin Nauth-Shelley, Michael A. Thompson, Deanna J. Attai, Matthew S. Katz, David Graham, Dee Sparacio, Christina Lizaso, Audun Utengen, and Don S. Dizon (Original Research)
BRD4 inhibition Is synthetic lethal with PARP inhibitors through the induction of homologous recombination deficiency, Chaoyang Sun, Jun Yin, Yong Fang, et al. (Article)
Androgen deprivation therapy for prostate cancer and incident atrial fibrillation, Zuber S. Ali, Tadele Mengesha, Suhail Allaqaband, et al. (Poster)
Metastatic recurrent hepatocellular carcinoma post liver transplant with marked pretransplant elevation of alpha fetoprotein and no evidence of primary neoplasm, Shiva Kumar (Article)
Association of 70-gene signature assay findings with physicians' treatment guidance for patients with early breast cancer classified as intermediate risk by the 21-gene assay, Michaela Tsai, Shelly Lo, William Audeh, et al. (Article)
Factors influencing first-line therapy of acute myeloid leukemia (AML) patients (pts) in the Connect MDS/AML Disease Registry, Christopher R Cogle, Michael A. Thompson, and et al (Abstract)
Lower extremity weakness in an adolescent female - a rare presentation of Ewing sarcoma, Luke Addesso, David Koenig, and Nadia Huq (Article)
Quantifying the effect of air gap, depth, and range shifter thickness on TPS dosimetric accuracy in superficial PBS proton therapy, Robert J. Shirey and Hsinshun Terry Wu (Article)
Reportable actionability versus pragmatic actionability: Implementing precision medicine at three large health systems, Michael A. Thompson, James Weese, Maharaj Singh, et al. (Abstract)
Successful automated normalization of cancer outcomes for half a million patients across four disparate health systems, Paul D. Tittel, Michael A. Thompson, James Weese, et al. (Abstract)
Works from 2017
Generation of a Patient-Derived Brain Metastasis Breast Cancer Cell Line via Novel Orthotopic Injection Placement and Serial Mouse Transplantation to Develop PDX Mouse Model, Amber L. LaCrosse, Denise M. Coley, Paul J. Mintz, Santhi D. Konduri, Richard A. Rovin, and Amin B. Kassam (Supplement)
Robustness of a Newly Proposed Risk Schema for Lymphatic Dissemination in Endometrioid Endometrial Cancer, Danielle M. Greer, Jessica J.F. Kram, Callie M. Cox Bauer, and Scott A. Kamelle (Supplement)
Multiple Myeloma Baseline Immunoglobulin G Level and Pneumococcal Vaccination Antibody Response, Michael A. Thompson, Martin K. Oaks, Maharaj Singh, Karen M. Michel, Michael P. Mullane, Husam S. Tarawneh, Angi Kraut, and Kayla J. Hamm (Brief Report)
Analysis of the use and impact of Twitter during American Society of Clinical Oncology annual meetings from 2011 to 2016: Focus on advanced metrics and user trends, Naveen Pemmaraju, Michael A. Thompson, Ruben A Mesa, et al. (Article)
The emerging role of professional social media use in oncology, Mina S Sedrak, Don S Dizon, Patricia F Anderson, et al. (Editorial)
Disulfram enhances Palbociclib and Abemaciclib activity through MGMT and CDK4/6 inhibition in breast cancer cells, Santhi Konduri, Deborah Donohoe, Dmitry Bosenko, et al. (Poster)
Robustness of a newly proposed risk schema for lymphatic dissemination of endometrioid endometrial cancer, Danielle M. Greer, Jessica J F Kram, Callie M. Cox Bauer, et al. (Poster)
Hormonal contraception and therapy use in breast cancer survivors: Do recurrence and mortality risks increase?, Sara Stanenas, Danielle M. Greer, Jessica J F Kram, et al. (Abstract)
Triathlon training for women breast cancer survivors: feasibility and initial efficacy, Alexander V Ng, Alyson N Cybulski, Ashley A Engel, et al. (Article)
Multiple Myeloma Vaccination Patterns in a Large Health System: A Pilot Study, Andinet Alemu, Maharaj Singh, Chris Blumberg, John O. Richards, Martin K. Oaks, and Michael A. Thompson (Original Research)
Predicting nonmuscle invasive bladder cancer recurrence and progression in a United States population, Kourosh Ravvaz, Marcus E Walz, John Weissert, et al. (Article)
Phase 1b trial of proteasome inhibitor carfilzomib with irinotecan in lung cancer and other irinotecan-sensitive malignancies that have progressed on prior therapy (Onyx IST reference number: CAR-IST-553), Susanne M Arnold, Kari Chansky, Markos Leggas, et al. (Article)
BRE12-158: A phase II randomized controlled trial of genomically directed therapy after preoperative chemotherapy in patients with triple negative breast cancer (TNBC), B Schneider, K D. Miller, S Badve, et al. (Abstract)
Enhanced recovery program and length of stay after laparotomy on a gynecologic oncology service: A randomized controlled trial, Elizabeth L. Dickson, Erica Stockwell, Melissa A Geller, et al. (Article)
Reaffirming and Clarifying the American Society of Clinical Oncology's Policy Statement on the Critical Role of Phase I Trials in Cancer Research and Treatment, Jeffrey S Weber, Laura A Levit, Peter C Adamson, et al. (Article)
Best practices and practical nuances in the treatment of gastric cancer in high-risk global areas, Federico A. Sanchez (Article)
Competitive funding strategies for the conquer cancer foundation of ASCO, Tanios Bekaii-Saab, Sanjay Goel, Adrien Dickerson, et al. (Article)
Practice model for advanced practice providers in oncology, Jamie Cairo, Mary Ann Muzi, Deanna Ficke, et al. (Article)
Works from 2016
Current diagnosis patterns for acute myeloid leukemia (AML) in clinical practice compared with World Health Organization (WHO) 2008 recommendations: outcomes from the CONNECT® Myelodysplastic Syndromes (MDS) and AML disease registry, Tracy I. George, Harry P. Erba, David P. Steensma, et al. (Abstract)
Global, prospective, non-interventional, observational study of presentation, treatment patterns, and outcomes in multiple myeloma patients: the Insight-MM Study, Robert M. Rifkin, Faith E. Davies, Antonio Palumbo, et al. (Abstract)
Multiple myeloma vaccination sequential immune response pilot study, Michael A. Thompson, Martin K. Oaks, John O Richards, et al. (Abstract)
Social media and myeloproliferative neoplasms (mpn): analysis of advanced metrics from the first year of a new twitter community: #mpnsm, Naveen Pemmaraju, Audun Utengen, Vikas Gupta, et al. (Article)
The impact of perioperative β blocker use on patient outcomes after primary cytoreductive surgery in high-grade epithelial ovarian carcinoma, Ahmed Al-Niaimi, Elizabeth L. Dickson, Cassandra Albertin, et al. (Article)
Determining the Incidence and Factors of Cardiotoxicity in Breast Cancer Patients Treated With Anthracycline and/or Trastuzumab-Containing Regimen at Aurora Health Care, Stephanie Ghojallu, Matthew Rappelt, Han-Yang Chen, Ruth Perez, Lydia Garlie, Geoffrey Riddell, Yingying Gu, Jun Zhang, Rubina Qamar, Bijoy K. Khandheria, Arshad Jahangir, and Yang Shi (Supplement)
Erratum to: NK cell-mediated antibody-dependent cellular cytotoxicity is enhanced by tamoxifen in HER2/neu non-amplified, but not HER2/neu-amplified, breast cancer cells, John O Richards, Alex J. Albers, Thomas S. Smith, et al. (Article)
NK cell-mediated antibody-dependent cellular cytotoxicity is enhanced by tamoxifen in HER2/neu non-amplified, but not HER2/neu-amplified, breast cancer cells, John O Richards, Alex J. Albers, Thomas S Smith, et al. (Article)
Risk factors of trastuzumab-induced cardiotoxicity in breast cancer: A meta-analysis, Zeeshan Jawa, Ruth M Perez, Lydia Garlie, et al. (Article)
Measures of appropriateness and value for breast surgeons and their patients: the american society of breast surgeons choosing wisely (®) initiative, Jeffrey Landercasper, Lisa Bailey, Tiffany S Berry, et al. (Article)
New primary palliative care (PC) model for community cancer clinics (CCC), Cheruppolil R. Santhosh-Kumar, Deborah Gray, Stephanie Struve, et al. (Abstract)
Addressing administrative and regulatory burden in cancer clinical trials: Summary of a stakeholder survey and workshop hosted by the American Society of Clinical Oncology and the Association of American Cancer Institutes, Julie M Vose, Laura A Levit, Patricia Hurley, et al. (Article)
Breast cancer diagnosed by stress SPECT sestamibi: The role of inverse gray-scale imaging, Khawaja Afzal Ammar, Armaan Shaikh, Michael Anigbogu, et al. (Article)
Extradigital glomus tumor: a rare etiology for wrist soft tissue mass, Justin E. Friske, Vipul Sharma, S A. Kolpin, et al. (Case Report)
Insights from building a new National Cancer Institute Community Oncology Research Network Program site, Thomas J. Saphner, Michael A. Thompson, Sara Planton, et al. (Article)
New insights into estrogenic regulation of O(6)-methylguanine DNA-methyltransferase (MGMT) in human breast cancer cells: Co-degradation of ER-α and MGMT proteins by fulvestrant or O(6)-benzylguanine indicates fresh avenues for therapy, Ameya Paranjpe, Nathan I Bailey, Santhi Konduri, et al. (Article)
Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study, David P Steensma, Medrdad Abedi, Rafael Bejar, et al. (Article)
Bell’s palsy as the initial presentation of multiple myeloma: A case report, Qiaofang Chen, Carol Huibregtse, and Cheruppolil R. Santhosh-Kumar (Case Report)
A Pilot Study of Circulating Tumor Cells in Stage IV Non-Small Cell Lung Carcinoma, Max Haid, Edward Chesna, Mary Theodoroff, Debra K. Spaeth, Cheruppolil R. Santhosh-Kumar, and Zahid N. Dar (Original Research)
Understanding Health Care Costs in a Wisconsin Acute Leukemia Population, Patricia Steinert and Ron A. Cisler (Original Research)
Social media and internet resources for patients with blastic plasmacytoid dendritic cell neoplasm (bpdcn), Naveen Pemmaraju, Vikas Gupta, Michael A. Thompson, et al. (Article)
Abstract 285: Disulfiram, a dual MGMT and aldehyde dehydrogenase inhibitor, sensitizes ER-positive breast cancer cells to temozolomide and cyclophosphamide, George C. Bobustuc, Deborah Donohoe, Alisher Holmuhamedov, et al. (Abstract)
Abstract 2594: clinical pathways as a platform to support clinical research, Peter G. Ellis (Abstract)
Social media in cancer care: highlights, challenges & opportunities, Deanna J Attai, Mina S Sedrak, Matthew S Katz, et al. (Article)
Challenges with research contract negotiations in community-based cancer research, Michael A. Thompson, Patricia A Hurley, Bryan Faller, et al. (Article)
An online tool to assess the quality of research programs, Renee Yvonne Smith, Patricia A. Hurley, Michael A. Thompson, et al. (Abstract)
Implementation of treatment pathways in a large integrated health care system, James Leighton Weese, Levi Citrin, Corey J. Shamah, et al. (Abstract)
Tumor diameter as a predictor of lymphatic dissemination in endometrioid endometrial cancer, Callie Cox Bauer, Danielle M. Greer, Jessica J. F. Kram, et al. (Article)
Selective omission of level V nodal coverage for patients with oropharyngeal cancer: Clinical validation of intensity-modulated radiotherapy experience and dosimetric significance, Pranshu Mohindra, Erich Urban, Jonathan D Pagan, et al. (Article)
Targeting Estrogen Receptor Beta in a Phase 2 Study of High-Dose Estradiol in Metastatic Triple-Negative Breast Cancer: A Wisconsin Oncology Network Study, Kari B Wisinski, Wei Xu, Amye J Tevaarwerk, et al. (Article)
Actionable biomarkers in a non-small cell lung cancer (NSCLC) clinical pathway (CP), Peter G. Ellis (Abstract)
Dexamethasone alone and in combination with desipramine, phenytoin, valproic acid or levetiracetam interferes with 5-ALA-mediated PpIX production and cellular retention in glioblastoma cells, Johnathan E Lawrence, Christopher J Steele, Richard A Rovin, et al. (Article)
Disease-specific hashtags for online communication about cancer care, Matthew S Katz, Audun Utengen, Patricia F Anderson, et al. (Article)
Effect on clinical trial participation by integration of a clinical pathway program into an electronic health record (EHR), Corey J. Shamah and Thomas J. Saphner (Abstract)
Engaging managing physicians in clinical staging prior to the initiation of cancer treatment, Anne Barry-Weers, Carol Huibregtse, Marija Bjegovich-Weidman, et al. (Abstract)
Integration of a clinical pathways software into an EHR in a large, multisite, hospital-affiliated community oncology setting, Corey J. Shamah, Thomas J. Saphner, Jacob C. Frick, et al. (Abstract)
The role of surgical primary tumor extirpation in de novo stage IV breast cancer in the era of targeted treatment, Judy A. Tjoe, Danielle M. Greer, and Ahmed Dalmar (Abstract)
Abstract S2-05: Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast cancer: outcomes from CALGB 40603 (Alliance), WM Sikov, DA Berry, CM Perou, et al. (Abstract)
Implementing survivorship care planning in a large integrated cancer program, M. Jamie Cairo, Carol Huibregtse, Adam Ferry, et al. (Abstract)
Metastatic bone disease: femur—tibia, Nicholas Webber (Book Chapter)
MGMT inhibition by disulfiram sensitizes ER+ breast cancer cells to temozolomide and cyclophosphamide, Santhi Konduri, Deborah Donohoe, Alisher Holmuhamednov, et al. (Poster)
Survivors speak: a qualitative analysis of motivational factors influencing breast cancer survivors' participation in a sprint distance triathlon, Karen M Robinson, Linda B Piacentine, Leslie J. Waltke, et al. (Article)
Works from 2015
Incidence of cutaneous malignant melanoma by socioeconomic status in Canada: 1992-2006, Stephanie E Johnson-Obaseki, Varant Labajian, Martin Corsten, et al. (Article)
Social Media and the practicing hematologist: Twitter 101 for the busy healthcare provider, Michael A. Thompson, Navneet S Majhail, William A Wood, et al. (Article)
A Meta-Analysis of Incidence and Risk Factors of Trastuzumab-Induced Cardiotoxicity in Breast Cancer, Zeeshan Ali Jawa, Ruth M. Perez, Lydia Garlie, Maharaj Singh, Rubina Qamar, Bijoy K. Khandheria, Arshad Jahangir, and Yang Shi (Supplement)
Does the Expression of Ki-67, p16 and COX-2 at Initial Diagnosis of Breast Atypia or Usual Ductal Hyperplasia Predict a Second Clinically Significant Event?, Judy A. Tjoe, Philippe Gascard, Jianxin Zhao, Gary F. Neitzel, Maharaj Singh, Brittany Last, James Marx, Thea Tlsty, and Sanjay Kansra (Supplement)
In Vitro Growth Suppression of Renal Carcinoma Cells by Curcumin, Santhi Konduri, Madhavi Latha Yadav Bangaru, Phu Thanh Do, Shenglin Chen, Jeffrey Woodliff, and Sanjay Kansra (Supplement)
In Vitro Growth Suppression of Renal Carcinoma Cells by Curcumin, Santhi D. Konduri, Madhavi Latha Yadav Bangaru, Phu Thanh Do, Shenglin Chen, Jeffrey Woodliff, and Sanjay Kansra (Original Research)
Mailed At-Home FIT Intervention to Increase Colorectal Screenings at Sixteenth Street Community Health Centers, Alexander V. Herrera, Brian Hilgeman, Michelle Buelow, and Melissa A. Lemke (Supplement)
PRACTC: Practice Readiness Academic Clinical Training Collaborative –– Gap Analysis to Advance Clinical Training for Nurse Practitioner Students, Jennifer Hartlaub, Mary Ann Muzi, M. Jamie Cairo, John R. Brill, James Weese, Kristin Rivera, Susan Hafemann, Ann M. Rohrer, Julia Schumacher, and Terri L. Vandenhouten (Supplement)
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer, Joseph A Sparano, Robert J Gray, Della F Makower, et al. (Article)
A phase 2 study of weekly temsirolimus and bortezomib for relapsed or refractory B-cell non-Hodgkin lymphoma: A Wisconsin Oncology Network study, Timothy S Fenske, Namrata M Shah, Kyung Mann Kim, et al. (Article)
Social Media and Myeloproliferative Neoplasms (MPN)-Focus on Twitter and the Development of a Disease-specific Community: #MPNSM, Naveen Pemmaraju, Vikas Gupta, Ruben Mesa, et al. (Article)
Incidence of differentiated thyroid cancer in Canada by City of residence, Martin Corsten, Matthew Hearn, James Ted McDonald, et al. (Article)
Improving quality metric adherence to minimally invasive breast biopsy among surgeons within a multihospital health care system, Judy A. Tjoe, Danielle M. Greer, Sue Ihde, et al. (Article)
Multimodality imaging in cardiooncology, Fausto Pizzino, Giampiero Vizzari, Rubina Qamar, et al. (Article)
‘Everyone is an individual’: providing individualized treatment in oncology, Michael A. Thompson (Article)
In support of a patient-driven initiative and petition to lower the high price of cancer drugs, A Tefferi, H Kantarjian, S V. Rajkumar, et al. (Article)
Role of endovascular stenting in radiation-induced stenosis of lower extremity veins, Harold K Elias, M. Fuad Jan, and Suhail Allaqaband (Case Report)
MGMT inhibition suppresses survivin expression in pancreatic cancer, George C. Bobustuc, Anand Patel, Michael A. Thompson, et al. (Article)
Role of surgical staging and adjuvant chemotherapy in the treatment of uterine carcinosarcoma, O. Cabrera, C. Cho, Ahmed Dalmar, et al. (Abstract)
Hepatology: Complete regression of locally advanced hepatocellular carcinoma following Sorafenib monotherapy, Shiva Kumar (Article)
Use of survivorship care plans to improve cost effective care following adjuvant treatment for breast cancer: e#42, Jean Rosiak (Abstract)
Integrated molecular pathology accurately determines the malignant potential of pancreatic cysts, MA Al-Haddad, T Kowalski, A Siddiqui, et al. (Article)
Breast Cancer Screening: Early Detection Is Not Enough, Judy A. Tjoe (Editorial)